Frank Reed

For years, dental health was seen as separate from overall well-being. Now, research reveals a powerful connection – and why your dentist may be key to preventing serious illness.

As CBD gains popularity, a growing need exists for informed patient-doctor discussions. One company is stepping up to bridge the knowledge gap and empower better healthcare conversations.

As personalized health gains traction, Parsley Health’s new Longevity Labs program offers a deeper dive into biomarkers—but how does it stack up against a rapidly growing field of competitors?

A new patient guide from leading organizations seeks to demystify genetic testing for prostate cancer, a rapidly evolving field offering personalized treatment options. But who benefits, and what are the potential drawbacks?

Direct-to-consumer epigenetic testing is booming, promising insights into biological age and health risks. But experts raise questions about accuracy, interpretation, and whether the science truly delivers on its promises.

A new direct-to-consumer epigenetic test aims to map aging at the organ level. We investigate the science, the cost, and the implications for the burgeoning longevity market.